Skip to content

Acupuncture on Bi'nao for hypophasis

Acupuncture on Bi'nao for hypophasis in Bell's palsy patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17012955
Enrollment
Unknown
Registered
2017-10-12
Start date
2017-10-01
Completion date
Unknown
Last updated
2017-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bell's palsy

Interventions

Real Bi'nao Group:Acupuncture therapy on conventional acu-points plus Bi'nao
Sham Bi'nao Group:Acupuncture therapy on conventional acu-points plus placebo point
Control Group:Acupuncture therapy on conventional acu-points

Sponsors

Baoshan Hospital of Integrated Traditional Chinese Medicine and Western Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients with Bell's palsy who are meeting the following inclusion criteria will be enrolled in the study: unilateral facial paralysis; age ranged from 18 to 60 years; Bell's palsy onset more than one month but less than three months; most symptoms recovered but hypophasis exist, the upper and lower eyelids distance larger than two millimeters; with negative pathological signs; without heart failure, liver function abnormalities, or other serious diabetes complications.

Exclusion criteria

Exclusion criteria: pregnancy or breastfeeding; woman of child bearing during the study period; patients who had received medicine or acupuncture therapy in other hospitals before this study; diabetes course =5 years, Grade 3 hypertension =3 years, and hyperlipidemia =3 years; history of malignant tumors, sexually transmitted disease, renal or hepatic disease, gastric or duodenal ulcer, glaucoma, acute otitis, ipsilateral chronic otitis, tuberculosis, immunodeficiency syndromes, recent head injury, psychiatric disease, infectious diseases, or any other conditions that is at risk of being influenced by the study treatment or that may affect the completion of the study; and patients participated in other clinical trials within 3 months.

Design outcomes

Primary

MeasureTime frame
Eye Crack Width Measurement;

Secondary

MeasureTime frame
Eyelid Strength Assessment;

Countries

China

Contacts

Public ContactLiu Zhidan

Baoshan Hospital of Integrated Traditional Chinese Medicine and Western Medicine

liuzhidan@vip.163.com+86 18916576769

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 6, 2026